(818) 356-8248 info@theacrm.com

Parkinson’s

Below is a sample of existing clinical evidence:
“At 6 weeks post-transplant two of four animals responded (decreased rotations by approximately 60%). At 12 weeks’ survival, three of four animals responded to the transplant (decreased rotations by approximately 60%). One animal in the 12-week survival group decreased rotations by 90%. In contrast, the PD (Parkinson’s Disease) animals that were not transplanted with UCMS (Umbilical Cord Matrix Stem) cells all showed a progressive degradation in performance following 6-OHDA.”

– “Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson’s Disease,” Weiss, Stem Cells, 2006

For further information regarding regenerative medicine, please refer to information provided by American Academy of Integrative Cell Therapy (AAICT).

Visit AAICT